NCT05462366 is a clinical trial of Sample collection in Healthy, sponsored by Zhujiang Hospital.

Who is sponsoring NCT05462366?

NCT05462366 is sponsored by Zhujiang Hospital.

What drugs are being tested in NCT05462366?

Interventions in NCT05462366: Sample collection.

What condition does NCT05462366 study?

NCT05462366 studies Healthy, Breast-milk Collection, Feces.

Is NCT05462366 still recruiting?

NCT05462366 is currently recruiting now. Last updated 25 July 2023.

Last reviewed 2023-07-25 · How we verify

NCT05462366

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Omics Sequencing of Specimen Derived From Mother-Infant-Pairs

Recruiting now Last updated 25 July 2023

What this trial tests

trial testing Sample collection in Healthy in 100 participants. Currently enrolling.

Timeline

22 June 2021

Primary endpoint
30 December 2024

30 December 2026

Quick facts

Lead sponsor	Zhujiang Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	22 June 2021
Primary completion	30 December 2024
Estimated completion	30 December 2026
Sites	1 location across China

Drugs / interventions tested

Sample collection — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →
Breast-milk Collection — all drugs for Breast-milk Collection →
Feces — all drugs for Feces →

Sponsor

Zhujiang Hospital

Who can join

Under 40, any sex, with Healthy or Breast-milk Collection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Microbial network signatures of early colonizers in infants with eczema.
Huang L, Pan G, Feng Y, Fan Z, et al · · 2023 · cited 12× · PMID 38868421 · DOI 10.1002/imt2.90
Effects of breast-fed infants-derived Limosilactobacillus reuteri and Bifidobacterium breve ameliorate DSS-induced colitis in mice.
Huang Z, Liu B, Xiao L, Liao M, et al · · 2024 · cited 9× · PMID 39351200 · DOI 10.1016/j.isci.2024.110902

Verify or expand the search:

Other trials of Sample collection

Trials testing the same drug.

NCT06634160 — Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozyg · recruiting
NCT04894370 — Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma · Phase 2 · recruiting
NCT06820151 — Exploring the Landscape of Injury and Repair in the Human Oesophagus · enrolling by invitation
NCT05937815 — Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor · NA · unknown
NCT04564183 — Advancing Prevention of Pulmonary Fibrosis · active not recruiting

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Zhujiang Hospital trials

Trials by the same sponsor.

NCT07335094 — A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lym · EARLY_PHASE1 · not yet recruiting
NCT07469072 — Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in t · Phase 2 · recruiting
NCT07455149 — An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines Wit · not yet recruiting
NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
NCT07454421 — Racecadotril for Organ Injury in Sepsis Patients · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05462366 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhujiang Hospital
Last refreshed: 25 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05462366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing